These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 16699793

  • 1. Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha.
    Miyake K, Tsuchida K, Sugino H, Imura S, Morine Y, Fujii M, Shimada M.
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):113-26. PubMed ID: 16699793
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP.
    Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
    [Abstract] [Full Text] [Related]

  • 3. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K, Ferdous T, Itashiki Y, Takii M, Mano T, Mori Y, Ueyama Y.
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [Abstract] [Full Text] [Related]

  • 4. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
    Wada H, Nagano H, Yamamoto H, Arai I, Ota H, Nakamura M, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Doki Y, Dono K, Nakamori S, Sakon M, Monden M.
    Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
    [Abstract] [Full Text] [Related]

  • 5. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW, Karashima T, Perrotte P, Inoue K, Kim SJ, Izawa J, Kedar D, McConkey DJ, Millikan R, Sweeney P, Yoshikawa C, Shuin T, Dinney CP.
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [Abstract] [Full Text] [Related]

  • 6. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y, Harada K, Ferdous T, Yoshida H.
    Anticancer Res; 2007 Sep; 27(4B):2365-75. PubMed ID: 17695527
    [Abstract] [Full Text] [Related]

  • 7. Interferon-alpha in combination with chemotherapy has potent antiangiogenic properties in an orthotopic mouse model for pancreatic adenocarcinoma.
    Zhu Y, Tibensky I, Schmidt J, Hackert T, Ryschich E, Jäger D, Büchler MW, Märten A.
    J Immunother; 2008 Jan; 31(1):28-33. PubMed ID: 18157009
    [Abstract] [Full Text] [Related]

  • 8. Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.
    Kim SJ, Uehara H, Karashima T, Shepherd DL, Killion JJ, Fidler IJ.
    Clin Cancer Res; 2003 Mar; 9(3):1200-10. PubMed ID: 12631626
    [Abstract] [Full Text] [Related]

  • 9. Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon alpha combined with paclitaxel.
    Tedjarati S, Baker CH, Apte S, Huang S, Wolf JK, Killion JJ, Fidler IJ.
    Clin Cancer Res; 2002 Jul; 8(7):2413-22. PubMed ID: 12114447
    [Abstract] [Full Text] [Related]

  • 10. Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors.
    Thaker PH, Yazici S, Nilsson MB, Yokoi K, Tsan RZ, He J, Kim SJ, Fidler IJ, Sood AK.
    Clin Cancer Res; 2005 Jul 01; 11(13):4923-33. PubMed ID: 16000591
    [Abstract] [Full Text] [Related]

  • 11. Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.
    Bockhorn M, Tsuzuki Y, Xu L, Frilling A, Broelsch CE, Fukumura D.
    Clin Cancer Res; 2003 Sep 15; 9(11):4221-6. PubMed ID: 14519649
    [Abstract] [Full Text] [Related]

  • 12. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma.
    Wang Z, Zhou J, Fan J, Qiu SJ, Yu Y, Huang XW, Tang ZY.
    Clin Cancer Res; 2008 Aug 15; 14(16):5124-30. PubMed ID: 18698030
    [Abstract] [Full Text] [Related]

  • 13. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.
    Clin Cancer Res; 2008 Apr 01; 14(7):2210-9. PubMed ID: 18381963
    [Abstract] [Full Text] [Related]

  • 14. S-1 inhibits tumorigenicity and angiogenesis of human oral squamous cell carcinoma cells by suppressing expression of phosphorylated Akt, vascular endothelial growth factor and fibroblast growth factor-2.
    Harada K, Supriatno, Kawashima Y, Yoshida H, Sato M.
    Int J Oncol; 2007 Feb 01; 30(2):365-74. PubMed ID: 17203218
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration.
    Dinney CP, Bielenberg DR, Perrotte P, Reich R, Eve BY, Bucana CD, Fidler IJ.
    Cancer Res; 1998 Feb 15; 58(4):808-14. PubMed ID: 9485039
    [Abstract] [Full Text] [Related]

  • 16. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
    Lee J, Wang A, Hu Q, Lu S, Dong Z.
    Int J Oncol; 2006 Dec 15; 29(6):1405-12. PubMed ID: 17088978
    [Abstract] [Full Text] [Related]

  • 17. Administration of optimal biological dose and schedule of interferon alpha combined with gemcitabine induces apoptosis in tumor-associated endothelial cells and reduces growth of human pancreatic carcinoma implanted orthotopically in nude mice.
    Solorzano CC, Hwang R, Baker CH, Bucana CD, Pisters PW, Evans DB, Killion JJ, Fidler IJ.
    Clin Cancer Res; 2003 May 15; 9(5):1858-67. PubMed ID: 12738744
    [Abstract] [Full Text] [Related]

  • 18. Combined effects of the oral fluoropyrimidine anticancer agent, S-1 and radiation on human oral cancer cells.
    Harada K, Kawaguchi S, Supriatno, Onoue T, Yoshida H, Sato M.
    Oral Oncol; 2004 Aug 15; 40(7):713-9. PubMed ID: 15172641
    [Abstract] [Full Text] [Related]

  • 19. The novel hypoxic cell radiosensitizer, TX-1877 has antitumor activity through suppression of angiogenesis and inhibits liver metastasis on xenograft model of pancreatic cancer.
    Miyake K, Shimada M, Nishioka M, Sugimoto K, Batmunkh E, Uto Y, Nagasawa H, Hori H.
    Cancer Lett; 2008 Dec 18; 272(2):325-35. PubMed ID: 18762366
    [Abstract] [Full Text] [Related]

  • 20. TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis.
    Bloomston M, Shafii A, Zervos EE, Rosemurgy AS.
    J Surg Res; 2002 Jan 18; 102(1):39-44. PubMed ID: 11792150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.